Namibia is set to spend over N$200 million annually on foot-and-mouth disease (FMD) vaccine acquisition from Botswana’s Vaccine Institute (BVI), as the country moves to contain any future outbreaks.Namibia is set to spend over N$200 million annually on foot-and-mouth disease (FMD) vaccine acquisition from Botswana’s Vaccine Institute (BVI), as the country moves to contain any future outbreaks.